Full name
BIOSYNTHESIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
BIOSYNTHESIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RUBIEŻ 46H / 229, 61-612 POZNAŃ
TAX ID9721257478
Rate company:
BIOSYNTHESIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9721257478
KRS0000571602
Share capital50,000.00 zł
address
UL. RUBIEŻ 46H / 229, 61-612 POZNAŃ
Website
www.biosynthesis.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9721257478
REGON
362522212
KRS
0000571602
Legal form
limited liability company
Register Address
UL. RUBIEŻ 46H / 229, 61-612 POZNAŃ
Date of registration in KRS
2015-09-18
Date of commencement of economic activity
2015-09-18
Act signature
RDF/660444/24/413
Website
WWW.BIOSYNTHESIS.PL
Pkd codes
72.11.Z - Research and experimental development on biotechnology
01.61.Z - Support activities for crop production
20.12.Z - Manufacture of dyes and pigments
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of perfumes and toilet preparations
68.20.Z - Rental and operating of own or leased real estate
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
Payer VAT status
Active
Vat list bank account(s)
PL47 1140 2004 0000 3502 7594 2932 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets  | 31,1 | 68,4 | 55 | -19,6 |
Gross profit (loss) | 0,8 | 28,1 | -10,8 | -138,4 |
EBITDA | 0,8 | 35,5 | -10,8 | -130,4 |
Net profit (loss) | 0,8 | 26,4 | -10,8 | -140,9 |
Cash | 12,5 | 5,4 | 42,5 | 685,6 |
Net income from sale | 3,9 | 65,6 | 35 | -46,6 |
Liabilities and provisions for liabilities | 1,3 | 12,2 | 9,6 | -21,6 |
Short time liabilities | 1,3 | 12,2 | 9,6 | -21,6 |
Working assets | 16,3 | 61 | 47,6 | -22 |
Equity capital | 29,8 | 56,2 | 45,4 | -19,2 |
Operating profit (EBIT) | 0,8 | 28,1 | -10,8 | -138,4 |
Depreciation | 0 | 7,4 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 2,6 | 46,9 | -23,7 | -70,6 |
Equity capital to total assets | 95,7 | 82,2 | 82,6 | 0,4 |
Gross profit margin | 20 | 42,8 | -30,8 | -73,6 |
EBITDA Margin | 20 | 54,1 | -30,8 | -84,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 123 | 68 | 100 | 32 |
Financial statements
01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
BioCraft Paweł Olszewski
Chwaszczyno
Molecular Biotech Mateusz Gielata
Warszawa
KATARZYNA PAWEŁCZYK SCINT
Wrocław
MR GREEN DOMINIK STATKIEWICZ
Szczecin